Living definition
What is mFLUSIVA (Moderna mRNA-1010)?
Vaccines & Immunotherapy Bio, Health & Neuro
- As of
- 2026-10-01
- Revision
- 2026-10-06.1
- Method
- v1.4.0
Definition
The term, in context
AI-assisted draft · approved dataset
mFLUSIVA (Moderna mRNA-1010) is a messenger RNA-based seasonal influenza vaccine that uses lipid nanoparticle-encapsulated mRNA encoding hemagglutinin antigens from multiple influenza strains, prompting host cells to produce the viral proteins so the immune system can generate a protective antibody response, applying the same synthetic mRNA platform architecture used in other mRNA prophylactic vaccines to seasonal flu immunization.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-10-01, verified readiness is 55 (claimed 55, reported 55, gap 0) — Strong evidence strength; current signals suggest Consider mFLUSIVA for its authorized adult population, with additional uncertainty for ages 65+.
The readiness fact belongs to the canonical Readiness Verdict for mFLUSIVA (Moderna mRNA-1010).
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06